Recent advances in type 1 diabetes

Abstract

• Type 1 diabetes (T1D) is caused by an autoimmune attack on pancreatic beta cells that leads to insulin deficiency. • The incidence of T1D in Australia has doubled over the past 20 years. • T1D treatment focuses on physiological insulin replacement, aiming for near-normal blood glucose levels. • Hypoglycaemia is a significant cause of morbidity and mortality in T1D. • Optimal T1D management is complex, and is enhanced by empowering individuals in all aspects of managing diabetes. • Newtechnologies, including insulin pumps, continuous glucose monitors and sensor-augmented pumps, can assist people achieve better glycaemic control and reduce the risk of severe hypoglycaemia. • Women with T1D c..